Renishaw posts record profit as semiconductor demand drives growth

Renishaw reported record annual profit, with revenue for the year ended June rising 14% to £815.8 million, or 17% at constant currency. Adjusted operating profit increased 36% to £152.9 million as strong semiconductor, aerospace and defence demand lifted both sales and margins.

Analysis

RSW’s earnings torque indicates that incremental revenue is converting at a materially higher rate than its historical run-rate, implying the current debate should shift from demand recovery to durability of mix and operating leverage. The key valuation risk is that semiconductor metrology demand is typically more cyclical than aerospace/defence precision-engineering demand; if investors capitalize peak semiconductor utilization as a structural margin reset, the multiple can become vulnerable even if absolute earnings remain healthy.

Over the next 1-3 months, the main catalyst is whether management frames current order intake and book-to-bill as broad-based rather than concentrated in a small number of semiconductor capital-equipment programs. A sustained mix shift toward defence, aerospace aftermarket and industrial automation would support higher through-cycle margins and make RSW a cleaner European precision-motion compounder; a deceleration in semiconductor orders would expose the stock to the same capex digestion concerns affecting ASML, AMAT and LRCX.

Second-order beneficiaries include UK-listed defence-electronics and precision-engineering peers such as HLMA and SNR, where higher customer investment in inspection, calibration and manufacturing automation can support demand. Conversely, the market may be underestimating RSW’s exposure to a normalization in semiconductor equipment spending: modest sequential order weakness could drive disproportionate EPS revisions because the recent profit expansion embeds favorable utilization and overhead absorption.

The contrarian view is constructive: RSW’s diversified end-market exposure may deserve less cyclicality discount than pure-play semiconductor equipment names, particularly if European defence procurement shifts from platform orders toward domestic production capacity and quality-control tooling. That thesis is falsified by a declining book-to-bill for two consecutive reporting periods, operating-margin guidance retreating below the current elevated range, or evidence that semiconductor-related sales are falling faster than aerospace/defence growth can offset.

Key Decisions for Investors

• Maintain or initiate a modest long RSW position on post-results liquidity, targeting a 6-12 month holding period; upside requires confirmation that elevated operating leverage is retained, while the stop/review trigger is a meaningful order-intake slowdown or margin-guide cut at the next update.
• Express the relative-value view as long RSW / short a semiconductor-capex proxy such as SOXX only after confirming RSW’s non-semiconductor order growth is accelerating. The pair benefits if aerospace, defence and industrial metrology reduce RSW’s earnings beta to wafer-fab equipment; avoid initiating without segment order data.
• Use a 1-3 month watch item around management commentary on book-to-bill, semiconductor customer inventory and pricing. If orders remain above revenue and margin guidance is maintained, add to RSW; if book-to-bill drops below 1.0x, reduce rather than buy the apparent valuation dip.
• Monitor HLMA and SNR as read-through beneficiaries of European precision-manufacturing and defence supply-chain investment, but do not treat the result as sufficient evidence for a sector-wide trade until peer order commentary corroborates the demand broadening.